Mumbai, March 10 -- The aforementioned product is a generic equivalent of 'MiraLAX Powder for Solution' of Bayer HealthCare LLC.

Polyethylene Glycol is an osmotic laxative. It prevents and treats occasional constipation.

According to Nielsen syndicated data for the latest 52 weeks' period ending 22 February 2025, the MiraLAX Powder for Solution OTC market achieved annual sales of approximately $555.7 million.

Marc Kikuchi, president & business head, North America, said: "We are excited to announce the launch of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful, addressing the growing demand for a new supplier in this category.

This addition highlights our commitment to meeting market needs and providing high-quality over-...